Literature DB >> 23684650

Functional interrogation of kinases and other nucleotide-binding proteins.

Jonathan S Rosenblum1, Tyzoon K Nomanbhoy, John W Kozarich.   

Abstract

The largest mammalian enzyme family is the kinases. Kinases and other nucleotide-binding proteins are key regulators of signal transduction pathways and the mutation or overexpression of these proteins is often the difference between health and disease. As a result, a massive research effort has focused on understanding how these proteins function and how to inhibit them for therapeutic benefit. Recent advances in chemical biological tools have enabled functional interrogation of these enzymes to provide a deeper understanding of their physiological roles. In addition, these innovative platforms have paved the way for a new generation of drugs whose properties have been guided by functional profiling.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23684650     DOI: 10.1016/j.febslet.2013.05.008

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

Review 1.  Global discovery of protein kinases and other nucleotide-binding proteins by mass spectrometry.

Authors:  Yongsheng Xiao; Yinsheng Wang
Journal:  Mass Spectrom Rev       Date:  2014-11-05       Impact factor: 10.946

2.  Chemical Proteomic Profiling of Human Methyltransferases.

Authors:  Benjamin D Horning; Radu M Suciu; Darian A Ghadiri; Olesya A Ulanovskaya; Megan L Matthews; Kenneth M Lum; Keriann M Backus; Steven J Brown; Hugh Rosen; Benjamin F Cravatt
Journal:  J Am Chem Soc       Date:  2016-09-30       Impact factor: 15.419

Review 3.  GLOBAL AND TARGETED PROFILING OF GTP-BINDING PROTEINS IN BIOLOGICAL SAMPLES BY MASS SPECTROMETRY.

Authors:  Ming Huang; Yinsheng Wang
Journal:  Mass Spectrom Rev       Date:  2020-06-10       Impact factor: 10.946

4.  High-resolution crystal structure of human asparagine synthetase enables analysis of inhibitor binding and selectivity.

Authors:  Wen Zhu; Ashish Radadiya; Claudine Bisson; Sabine Wenzel; Brian E Nordin; Francisco Martínez-Márquez; Tsuyoshi Imasaki; Svetlana E Sedelnikova; Adriana Coricello; Patrick Baumann; Alexandria H Berry; Tyzoon K Nomanbhoy; John W Kozarich; Yi Jin; David W Rice; Yuichiro Takagi; Nigel G J Richards
Journal:  Commun Biol       Date:  2019-09-17

5.  KSR induces RAS-independent MAPK pathway activation and modulates the efficacy of KRAS inhibitors.

Authors:  Guillem Paniagua; Harrys K C Jacob; Oksana Brehey; Sara García-Alonso; Carmen G Lechuga; Tirso Pons; Monica Musteanu; Carmen Guerra; Matthias Drosten; Mariano Barbacid
Journal:  Mol Oncol       Date:  2022-04-12       Impact factor: 7.449

6.  Proteome-wide Map of Targets of T790M-EGFR-Directed Covalent Inhibitors.

Authors:  Sherry Niessen; Melissa M Dix; Sabrina Barbas; Zachary E Potter; Shuyan Lu; Oleg Brodsky; Simon Planken; Douglas Behenna; Chau Almaden; Ketan S Gajiwala; Kevin Ryan; RoseAnn Ferre; Michael R Lazear; Matthew M Hayward; John C Kath; Benjamin F Cravatt
Journal:  Cell Chem Biol       Date:  2017-09-28       Impact factor: 8.116

7.  A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors.

Authors:  Bryan R Lanning; Landon R Whitby; Melissa M Dix; John Douhan; Adam M Gilbert; Erik C Hett; Theodore O Johnson; Chris Joslyn; John C Kath; Sherry Niessen; Lee R Roberts; Mark E Schnute; Chu Wang; Jonathan J Hulce; Baoxian Wei; Laurence O Whiteley; Matthew M Hayward; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2014-07-13       Impact factor: 15.040

8.  Demonstration of In Vitro to In Vivo Translation of a TYK2 Inhibitor That Shows Cross Species Potency Differences.

Authors:  Brian S Gerstenberger; Mary Ellen Banker; James D Clark; Martin E Dowty; Andrew Fensome; Roger Gifford; Matthew C Griffor; Martin Hegen; Brett D Hollingshead; John D Knafels; Tsung H Lin; James F Smith; Felix F Vajdos
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.